QNCX
QNCX
NASDAQ · Biotechnology

Quince Therapeutics Inc

$0.10
+0.01 (+13.70%)
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 0 0%
Hold 5 56%
Sell 4 44%
Price Target
Analyst Price Target +40,201.2% upside
Low Target $31.69
Average Target $40.14
High Target $63.06
Current Price $0.10
Current
$0.10
Target
$40.14
$31.69 $40.14 avg $63.06
Scenario Analysis
Bear Case
$31.69
31,717.3%
Low target
Base Case
$40.14
+40,201.2%
Avg target
Bull Case
$63.06
+63,213.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$4.55
-97.8% from high
52-Week Low
$0.08
+24.5% from low
Target vs 52W High
$40.14
+782.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%